AFS
VRTX icon

Annapolis Financial Services’s Vertex Pharmaceuticals VRTX Stock Holding History

Annapolis Financial Services’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$30.2K Buy
65
+1
+2% +$480 0.01% 193
2024
Q2 		$30K Hold
64
– – 0.01% 190
2024
Q1 		$26.8K Buy
+64
New +$27.1K 0.01% 199
2023
Q4 		– Sell
-6
Closed -$2.09K – 504
2023
Q3 		$2.09K Hold
6
– – ﹤0.01% 431
2023
Q2 		$2.11K Buy
+6
New +$2.02K ﹤0.01% 434
2022
Q1 		– Sell
-20
Closed -$4K – 510
2021
Q4 		$4K Sell
20
-39
-66% -$7.58K ﹤0.01% 379
2021
Q3 		$11K Buy
+59
New +$11.5K ﹤0.01% 287
2021
Q2 		– Sell
-17
Closed -$4K – 469
2021
Q1 		$4K Buy
+17
New +$3.73K ﹤0.01% 328

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Annapolis Financial Services's VRTX Position: Q3 2024 in Review

Annapolis Financial Services increased its Vertex Pharmaceuticals (VRTX) stake by 1.6% in Q3 2024, buying an estimated $480 and bringing the position to 65 shares worth $30.2K. The position accounts for 0.01% of the portfolio, ranked #193.

Annapolis Financial Services first reported a position in VRTX in Q1 2021 and has held it in 8 quarters since. 1,544 funds tracked by Wall St. Rank hold VRTX as of Q3 2024.

  • Annapolis Financial Services held 65 shares of Vertex Pharmaceuticals worth $30.2K as of Q3 2024.
  • Annapolis Financial Services bought 1 Vertex Pharmaceuticals share in Q3 2024, an estimated $480.
  • Vertex Pharmaceuticals made up 0.01% of Annapolis Financial Services's portfolio in Q3 2024, its #193 holding.
  • Annapolis Financial Services first reported a position in Vertex Pharmaceuticals in Q1 2021 and has held it in 8 quarters since.
  • 1,544 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2024.

Based on Annapolis Financial Services's 13F filing for Q3 2024, filed 16 Oct 2024.